Contact-and agonist-regulated microvesiculation of human platelets

Thrombosis and Haemostasis

Volumn 110, Issue 2, 2013, Pages 331-339

  Zhang, Yanjun ^a,b   Liu, Xiao ^b   Liu, Li ^a   Zaske, Ana Maria ^c   Zhou, Zhou ^d,e   Fu, Yuanyuan ^d,e   Yang, Xi ^b   Conyers, Jodie L ^c   Li, Min ^f   Dong, Jing Fei ^d,g   Zhang, Jianning ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b China National Academy of Nanotechnology and Engineering   (China)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d PUGET SOUND BLOOD CENTER   (United States)

^e INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^f LANZHOU UNIVERSITY   (China)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Anti platelet drugs; Contact inhibition; Microvesiculation; Platelets

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ACETYLSALICYLIC ACID; BETA3 INTEGRIN; CALCIMYCIN; CLOPIDOGREL; CYTOCHALASIN D; FIBRINOGEN;

AGONIST; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL STRUCTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NORMAL HUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; VESICULATION;

ADENOSINE DIPHOSPHATE; ASPIRIN; BLOOD PLATELETS; CELL SHAPE; CELL-DERIVED MICROPARTICLES; FIBRINOGEN; HUMANS; MICROSCOPY, ATOMIC FORCE; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 84880790423     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-11-0853     Document Type: Article

References (35)

1. Zwaal RF, et al. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005; 62: 971-988.
2. Sinauridze EI, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97: 425-434.
3. Connor DE, et al. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010; 103: 1044-1052.
4. Pasquet JM, et al. Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem 1996; 239: 647-654.
5. Italiano JE, Jr., et al. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 2010; 17: 578-584.
6. Moroi M, et al. Involvement of activated integrin alpha2beta1 in the firm adhesion of platelets onto a surface of immobilized collagen under flow conditions. Thromb Haemost 2000; 83: 769-776.
7. Ratajczak J, et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20: 1487-1495.
8. van der Zee PM, et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 2006; 52: 657-664.
9. Baj-Krzyworzeka M, et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chaemotaxis of hematopoietic cells. Exp Hematol 2002; 30: 450-459.
10. Henseleit U, et al. Effects of divalent cations on lipid flip-flop in the human erythrocyte membrane. Biochim Biophys Acta 1990; 1029: 127-135.
11. Shcherbina A, et al. Role of caspase in a subset of human platelet activation responses. Blood 1999; 93: 4222-4231.
12. Dale GL, Friese P. Bax activators potentiate coated-platelet formation. J Thromb Haemost 2006; 4: 2664-2669.
13. Schoenwaelder SM, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 2009; 114: 663-666.
14. Heemskerk JW, et al. Platelet activation and blood coagulation. Thromb Haemost 2002; 88: 186-193.
15. Bevers EM, et al. Exposure of endogenous phosphatidylserine at the outer surface of stimulated platelets is reversed by restoration of aminophospholipid translocase activity. Biochemistry 1989; 28: 2382-2387.
16. Bird GS, et al. Mechanisms of phospholipase C-regulated calcium entry. Curr Mol Med 2004; 4: 291-301.
17. Fox JE, et al. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem 1991; 266: 13289-13295.
18. Zhang H, et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ 2007; 14: 943-951.
19. Mason KD, et al. Programmed anuclear cell death delimits platelet life span. Cell 2007; 128: 1173-1186.
20. Liu X, et al. High-resolution morphological identification and characterisation of living neuroblastoma SK-N-SH cells by hopping probe ion conductance microscopy. Brain Res 2011; 1386: 35-40.
21. Yang X, et al. Investigation of morphological and functional changes during neuronal differentiation of PC12 cells by combined Hopping Probe Ion Conductance Microscopy and patch-clamp technique. Ultramicroscopy 2011; 111: 1417-1422.
22. Novak P, et al. Nanoscale live-cell imaging using hopping probe ion conductance microscopy. Nat Methods 2009; 6: 279-281.
23. Shah MD, et al. Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets 2008; 19: 365-372.
24. Berckmans RJ, et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639-646.
25. Yan R, et al. Role of cAMP-dependent protein kinase in the regulation of platelet procoagulant activity. Arch Biochem Biophys 2009; 485: 41-48.
26. Noe L, et al. Regulators of platelet cAMP levels: clinical and therapeutic implications. Curr Med Chem 2010; 17: 2897-2905.
27. Vlahos CJ, et al. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994; 269: 5241-5248.
28. Gilio K, et al. Non-redundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signalling and thrombus formation. J Biol Chem 2009; 284: 33750-33762.
29. Flaumenhaft R, et al. Platelet- and megakaryocyte-derived microparticles. Semin Thromb Haemost 2010; 36: 881-887.
30. Leytin V, et al. Thrombin-triggered platelet apoptosis. J Thromb Haemost 2006; 4: 2656-2663.
31. Lin KH, et al. Comparison of the relative activities of inducing platelet apoptosis stimulated by various platelet-activating agents. Platelets 2009; 20: 575-581.
32. Cauwenberghs S, et al. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilisation of actin cytoskeleton. FEBS Lett 2009; 580: 5313-5320.
33. 2+ responses. Blood 1997; 90: 2615-2625.
34. Razmara M, et al. Glycoprotein IIb/IIIa blockade inhibits platelet aminophospholipid exposure by potentiating translocase and attenuating scramblase activity. Cell Mol Life Sci 2007; 64: 999-1008.
35. Behan MW, et al. Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes. Platelets 2005; 16: 73-80.